|
|
GuidelineStat™
Managing Hormone Receptor Positive Breast Cancer in the Clinical Setting
GuidelineStat™ Managing Hormone Receptor Positive (HR+) Breast Cancer in the Clinical Setting
is a CME initiative developed in conjunction with a leading expert from the Keck School of
Medicine at the University of Southern California, that provides evidence-based guideline
content for the treatment and management of HR+ Breast Cancer.
This learning activity has been designated for a maximum of 1.25 AMA PRA Category 1 Credits™.
Imedex, LLC is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
After reviewing this module, the participant will be better able to:
- Explain adjuvant therapy options available for the patient with HR+ breast cancer according to the NCCN Practice Guidelines for Breast Cancer
- Review appropriate timing of tamoxifen and / or aromatase inhibitor therapy according to current guidelines
View all Learning Objectives and Enter Module.
|
Content Highlights
|
|
Editorial Faculty
Christy A. Russell, MD
Associate Professor of
Clinical Medicine
Co-director
USC/Norris Lee Breast Center
Keck School of Medicine of
University of Southern California
Los Angeles, California
|
This educational activity was made possible through an unrestricted educational grant from:
|